Margaux Lecacheur

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 7

Top Topics

Metastatic Colorectal Cancer

Pseudomonas Aeruginosa

Basal Cell Carcinoma

Finite Element Analysis

Top Venues

Nature communications

EMBO molecular medicine

Cancer research

This page only lists publications with an associated author ORCID identifier.

Publications

Alessandro Poli, Fabrizio A Pennacchio, Andrea Ghisleni, Mariagrazia di Gennaro, Margaux Lecacheur, Paulina Nastały, Michele Crestani, Francesca Michela Pramotton, Fabio Iannelli, Galina V Beznoussenko, Alexander A Mironov, Valeria Panzetta, Sabato Fusco, Bhavwanti Sheth, Dimos Poulikakos, Aldo Ferrari, Nils Gauthier, Paolo A Netti, Nullin Divecha, Paolo Maiuri
PIP4K2B is mechanoresponsive and controls heterochromatin-driven nuclear softening through UHRF1. Nature communications 14 (1) (2023)
Alessandro Poli, Fabrizio A Pennacchio, Andrea Ghisleni, Mariagrazia di Gennaro, Margaux Lecacheur, Paulina Nastały, Michele Crestani, Francesca Michela Pramotton, Fabio Iannelli, Galina V Beznoussenko, Alexander A Mironov, Valeria Panzetta, Sabato Fusco, Bhavwanti Sheth, Dimos Poulikakos, Aldo Ferrari, Nils Gauthier, Paolo A Netti, Nullin Divecha, Paolo Maiuri
PIP4K2B is mechanoresponsive and controls heterochromatin-driven nuclear softening through UHRF1. Nature communications 14 (1) (2023)
Alessandro Poli, Fabrizio A Pennacchio, Andrea Ghisleni, Mariagrazia di Gennaro, Margaux Lecacheur, Paulina Nastały, Michele Crestani, Francesca Michela Pramotton, Fabio Iannelli, Galina V Beznoussenko, Alexander A Mironov, Valeria Panzetta, Sabato Fusco, Bhavwanti Sheth, Dimos Poulikakos, Aldo Ferrari, Nils Gauthier, Paolo A Netti, Nullin Divecha, Paolo Maiuri
PIP4K2B is mechanoresponsive and controls heterochromatin-driven nuclear softening through UHRF1. Nature communications 14 (1) (2023)
Alessandro Poli, Fabrizio A Pennacchio, Andrea Ghisleni, Mariagrazia di Gennaro, Margaux Lecacheur, Paulina Nastały, Michele Crestani, Francesca Michela Pramotton, Fabio Iannelli, Galina V Beznoussenko, Alexander A Mironov, Valeria Panzetta, Sabato Fusco, Bhavwanti Sheth, Dimos Poulikakos, Aldo Ferrari, Nils Gauthier, Paolo A Netti, Nullin Divecha, Paolo Maiuri
PIP4K2B is mechanoresponsive and controls heterochromatin-driven nuclear softening through UHRF1. Nature communications 14 (1) (2023)
Christopher Rovera, Ilona Berestjuk, Margaux Lecacheur, Cassandre Tavernier, Serena Diazzi, Sabrina Pisano, Marie Irondelle, Aude Mallavialle, Jean Albrengues, Cédric Gaggioli, Christophe A Girard, Thierry Passeron, Marcel Deckert, Sophie Tartare-Deckert, Virginie Prod'homme
Secretion of IL1 by Dedifferentiated Melanoma Cells Inhibits JAK1-STAT3-Driven Actomyosin Contractility of Lymph Node Fibroblastic Reticular Cells. Cancer research 82 (9) (2022)
Serena Diazzi, Alberto Baeri, Julien Fassy, Margaux Lecacheur, Oskar Marin-Bejar, Christophe A Girard, Lauren Lefevre, Caroline Lacoux, Marie Irondelle, Carine Mounier, Marin Truchi, Marie Couralet, Mickael Ohanna, Alexandrine Carminati, Ilona Berestjuk, Frederic Larbret, David Gilot, Georges Vassaux, Jean-Christophe Marine, Marcel Deckert, Bernard Mari, Sophie Tartare-Deckert
Blockade of the pro-fibrotic reaction mediated by the miR-143/-145 cluster enhances the responses to targeted therapy in melanoma. EMBO molecular medicine 14 (3) (2022)
Ilona Berestjuk, Margaux Lecacheur, Alexandrine Carminati, Serena Diazzi, Christopher Rovera, Virginie Prod'homme, Mickael Ohanna, Ana Popovic, Aude Mallavialle, Frédéric Larbret, Sabrina Pisano, Stephane Audebert, Thierry Passeron, Cédric Gaggioli, Christophe A Girard, Marcel Deckert, Sophie Tartare-Deckert
Targeting Discoidin Domain Receptors DDR1 and DDR2 overcomes matrix-mediated tumor cell adaptation and tolerance to BRAF-targeted therapy in melanoma. EMBO molecular medicine 14 (2) (2021)